Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00054496
Title Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Cleveland Clinic
Indications

glioblastoma

Therapies

Erlotinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.